FDA NDC Directory · JSON-LD · Markdown

BENZONATATE

NDC 67877-575 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerAscend Laboratories, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA040627
Dosage form / routeCAPSULE · ORAL
Active ingredientsBENZONATATE (200 mg/1)
Marketing started20170322
Package count2

External sources

Source: openFDA. Public-domain (CC0).